Invest in intelligence that delivers

Contact
Search
Close this search box.

Spherix Offering

Stay ahead of the curve and uncover emerging healthcare trends to strengthen your strategy & tactics.

Capitalize on commercially relevant market insights across the lifecycle.

Our strategic advisory services combine robust, independent market data and deep therapeutic expertise to deliver unparalleled commercial value.

Independent, holistic intelligence informs tailored support that matches the needs of your business.

Our continuous market intelligence provides an unbiased view of the landscape within rapidly evolving specialty markets, including quarterly market trending and a fresh infusion of event-driven and variable content with each wave of research.

Understand the prescriber’s perspective of the competitive landscape.

RealTime Dynamix™ delivers robust, unbiased brand and class trending of KPIs.
  • See the market from the prescriber’s point of view
  • Market trending, core rotational content, and event-driven & variable content with each wave, exploring:
    • Brand use, intentions, promotional activity
    • Disease awareness, controversy
    • Pipeline product perceptions
Methodology:
  • Insights based on data from an online surveys of respondents recruited from the Spherix Network, a proprietary group of screened practicing specialty physicians.
Sample Size & Frequency:

Reveal the ‘why’ behind treatment decisions and understand the patient journey.

Patient Chart Dynamix™ audits help you develop patient profiles and uncover opportunities.
  • Capture data not available in claims by tapping into rigorous analysis of large-scale patient chart audits
  • Understand differences between stated and actual treatment patterns with specialists’ attitudinal & demographic data
  • See how clinical trial populations compare to real patient management patterns and identify secondary endpoints that will allow for differentiation
Methodology:
  • Insights are based on patient-level data gathered through collaboration with specialty physicians who provide details on clinical and non-clinical patient demographics, along with rationale for treatment choices.
Sample Size & Frequency:

Independently assess launches and benchmark history of analogs.

Monthly KPI benchmarking of newly launched products (first 18 months), augmented by 6 quarterly deep dives, including qualitative interviews, focusing on:
  • Drivers and barriers of uptake
  • Promotional activity
  • Patient types gravitating to the launch brand
  • Competitive analyses
Methodology:
  • Insights are based on analyses of quantitative data from an online survey of physicians recruited from the Spherix Network, as well as qualitative interviews with a subset of survey respondents.
Sample Size & Frequency:

Gain an unbiased perspective of the market and its potential.

Market Dynamix™ reports blend data from specialists and leading KOLs.

  • Market size and current treatment approaches
  • What is needed to support early adoption and optimization of an asset
  • Unmet needs and attributes most desired in new therapeutics
  • Expert opinions on the likely disruption introduced by pipeline agents

Methodology:

  • Insights are based on analyses of quantitative data from an online survey of specialists, and leading KOLs recruited from the Spherix Network, as well as qualitative interviews with a subset of survey respondents and select KOLs.


Sample Size & Frequency:

Add context to trending topics and gauge the impact of disruptive events.

Special Topix™ reports on trending events and topics of interest in specialty markets.
  • Gain an objective perspective and context into the real issues influencing market shifts
  • Understand the prescriber’s perspective on trending topics and disruptive events
  • Gather insights on initial and potential lasting impacts on existing commercial brands
  • Deep dive into the mindset of fellows & residents
Methodology:
  • Insights are based on data from an online survey of respondents recruited from the Spherix Network, a proprietary group of specialty physicians in clinical practice meeting quality screening criteria.
Sample Size & Frequency:
  • Report cadence and deliverable depend upon current event/topic being evaluated.

Take advantage of the complete Spherix offering.

Spherix clients have exclusive access to…

Fortify your strategy and tactics with our industry experts who are well-versed in your situation and well-equipped to deliver strategic advisory services across the product lifecycle.

Gain context and insight into the dynamics both in and out of your market basket.

Our unparalleled market intelligence provides a broad and unbiased view of the landscape within rapidly evolving specialty markets, helping you to uncover emerging healthcare trends and strengthen your strategy & tactics.

Gain a competitive edge with the perspective of the extensive Spherix Physician Community, which includes our direct relationships with leading KOLs and a proprietary group of specialty physicians in clinical practice meeting quality screening criteria.

Interactive on-site or virtual sessions with Spherix therapeutic experts, highlighting commercially relevant analyses, contextual data, and custom insights and advisory services tailored to your business.

Thought partners at your fingertips: Our therapeutic experts are always just a click or call away, plugged into the ever-evolving landscape, ready to provide an unbiased view of the landscape, insightfully answer real-time questions, highlight opportunities, and identify disruptors.

Subscribed clients get access to our studies 3+ business days before public release.

Clients have access to the Spherix Analytics & Insights team to perform any ad hoc analyses and customized views of the research.
Spherix analysts and panel team can match your targeted call list against our panel and survey respondents, providing teams the validation that our surveys are reaching your targets, and allowing for advanced analyses on targeted physicians vs. non-targeted physicians.
Clients can add personalized and proprietary insights to their reports by adding one to two client-private questions into surveys – providing a customized take on the market.
Visit our portal to see the full spectrum of what Spherix has to offer across therapeutic areas. Clients can easily search and find all subscribed data and insights from the past 12 months.

We deliver commercial value by combining independent primary research and customized strategic insights.

Our team of specialty experts analyze independent syndicated datasets through the lens of your distinct situation, providing tailored considerations and contextual data that fuel decision-making.

Visit our portal to see the full spectrum of what Spherix has to offer across therapeutic areas.

Visit the Spherix portal
Sign up for alerts, market insights and exclusive content in your inbox.
Subscribe
Linkedin

Download our publication plan

or

Visit our portal for the searchable format

©2024 Spherix. All Rights Reserved.

Site Map

Sign up for alerts, market insights and exclusive content in your inbox.

Spherix is excited to announce our expansion into an additional, rapidly evolving specialty market:

HEMATOLOGY

Throughout 2024, we will be publishing over
10 groundbreaking studies covering a wide range of indications within classical hematology.